MonoSol must face states’ Suboxone complaint

Charles McConnell

01 November 2017

Just two weeks after dismissing Reckitt Benckiser Healthcare from an antitrust lawsuit alleging it monopolised the production of its opioid treatment drug Suboxone, a federal judge in Pennsylvania ruled that co-defendant MonoSol must face the claims.

Subscribe to Global Competition Review

Subscribe to unlock unlimited access

Get news, unique commentary, expert analysis and essential resources from the Global Competition Review experts.

Subscribe now

Already have access? Login below

Charles McConnell

View full biography

Author | Senior correspondent, Global Competition Review

[email protected]

Tipline

Keeping up with the Jones: The Tipline for 21 March 2023
Hausfeld still operates at the front of the pack of the plaintiffs’ antitrust bar, even after a shuffling of leadership that has seen founder Michael Hausfeld retire and the departure of Bonny Sweeney to the Department of Justice. The firm has responded by hiring a former litigation counsel from the New York attorney general’s office and promoting partner Megan Jones to co-chair its antitrust practice.
Order up: The Tipline for 20 March 2023
Don’t text and wage-fix: The Tipline for 17 March 2023